跳至主要内容
临床试验/NCT01746693
NCT01746693Unknown不适用

Neurovascular Coupling in Subjects With Amblyopia

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
2
主要终点
Retinal Vessel Diameter in Response to Flickering Light (DVA)

研究概览

简要总结

Amblyopia is a developmental condition that is characterized by reduced vision of the eye due to the presence of a sensory impediment during visual development, such as strabismus (ocular misalignment) or anisometropia (unequal refractive error), occurring early in life. Recent studies in humans and animals point towards a cortical locus for the processing deficit in amblyopia, revealing sensory deficits at the signal cell level. If changes in retinal neuronal function are also present, is unknown.

Like in the brain, blood flow in the retina is coupled to neuronal activity. This phenomenon has been measured by different study groups with non invasive techniques in the brain and retina. It has been shown in previous studies that stimulating the retina with diffuse luminant flickering light increases retinal vessel diameter and blood flow. However, it is unknown whether this is also the case in the retina of amblyopic eyes. Additionally, the introduction of blood oxygen level dependent (BOLD) fMRI also makes it possible to directly access the vascular response in the brain to visual stimuli.

Therefore, the aim of the present study is to investigate the effect of luminant flickering light on retinal vessel diameter and retinal blood flow in subjects with amblyopia. Also, oxygen saturation in retinal vessels will be assessed as well as pattern ERG for assessment of retinal function. Additionally, a high resolution image of the visual pathway will be taken with 7 Tesla MRI to investigate whether anatomical or functional alterations are present.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women aged between 18 and 55 years
  • Non-smokers (for at least 6 months)
  • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
  • Normal ophthalmic findings except amblyopia on one eye resulting from anisometropia or strabismus with a visual acuity of Snellen ≤ 0.3 with best correction on the amblyopic eye and Snellen 0.9 or better in the contralateral eye (for subjects with amblyopia)
  • Normal ophthalmic findings with visual acuity of Snellen ≥ 1.0 in both eyes (for control subjects)

排除标准

  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • Presence or history of a severe medical condition as judged by the clinical investigator
  • Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study (except oral contraceptives)
  • Blood donation during the previous three weeks
  • Pregnancy, planned pregnancy or lactating
  • Any metallic, electric, electronic or magnetic device or object not removable except dental fillings
  • Claustrophobia
  • Epilepsia, history or family history of seizures

结局指标

主要结局

Retinal Vessel Diameter in Response to Flickering Light (DVA)

时间窗: once on the study day

次要结局

  • Retinal (arterial and venous) oxygen saturation(once on the study day)
  • Retinal blood velocity in response to flickering light(once on the study day)
  • High resolution functional and anatomical imaging of the visual pathway(once on the study day)
  • Inner Retinal Function(once on the study day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gerhard Garhofer

Assoc. Prof. PD Dr.

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验